Article info

Download PDFPDF

EPV004/#360 Inhibition of cancer cell-dependent glycolysis through AVB-500, a selective inhibitor of gas6-axl, in combination with paclitaxel in high-grade endometrial cancer
Free

Authors

Citation

Bruce S, Lomonosova E, Noia H, et al
EPV004/#360 Inhibition of cancer cell-dependent glycolysis through AVB-500, a selective inhibitor of gas6-axl, in combination with paclitaxel in high-grade endometrial cancer

Publication history

  • First published November 1, 2021.
Online issue publication 
January 08, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.